For help on how to get the results you want, see our search tips.
105 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
-
List item
Referral: Numeta G13%E and Numeta G16%E emulsion for infusion
Article 107i procedures
Status: CMDh final position, opinion/position date: 18/09/2013, Last updated: 27/09/2013 -
List item
Referral: Suvaxyn Parvo/E
Articles 39 and 40
Status: European Commission final decision, opinion/position date: 17/01/2007, EC decision date: 17/04/2007, Last updated: 15/11/2007 -
List item
Referral: Cozaar Comp
losartan + hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008 -
List item
Referral: Suvaxyn Ery
Articles 39 and 40
Status: European Commission final decision, opinion/position date: 17/01/2007, EC decision date: 19/04/2007, Last updated: 15/11/2007 -
List item
Referral: Agopton
Lansoprazole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/09/2006, EC decision date: 13/12/2006, Last updated: 20/12/2006 -
List item
Referral: Amoxil
amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016 -
List item
Referral: Arimidex
anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011 -
List item
Referral: Atacand
candesartan, associated names: Amias, Blopress, Kenzen, Racanda, Ratacand, Parapres, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 13/07/2010, Last updated: 16/03/2011 -
List item
Referral: Atacand Plus
candesartan / hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011 -
List item
Referral: Augmentin
amoxicillin and clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013 -
List item
Referral: Calcichew D3
Calcium 500 mg / cholecalciferol 10 µg, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Calcichew D3 mite
Calcium 500 mg / cholecalciferol 5 µg, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Calcitugg
Calcium carbonate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Calcium Sandoz
Calcium lactate gluconate, Calcium carbonate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 09/08/2005, Last updated: 09/08/2005 -
List item
Referral: Ciprofloxacin Bayer
ciprofloxacin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 07/10/2008, Last updated: 23/10/2008 -
List item
Referral: Clenil and associated names
beclometasone dipropionate, associated names: Becloneb, Beclospin and Sanasthmax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/09/2016, EC decision date: 11/11/2016, Last updated: 18/11/2016 -
List item
Referral: Coversyl
Perindopril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 04/12/2003, Last updated: 23/12/2003 -
List item
Referral: Cozaar
losartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008 -
List item
Referral: Cymevene
ganciclovir, associated names: Cymevan, Citovirax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 21/06/2016 -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone / ethinylestradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013 -
List item
Referral: Daivobet
calcipotriol and betamethasone, associated names: Dovobet, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 30/09/2010, Last updated: 26/04/2011 -
List item
Referral: Diflucan
fluconazole, associated names: Fluconazole, Fungustatin, Fungata, Triflucan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 02/09/2011, Last updated: 02/02/2012 -
List item
Referral: Diovan
valsartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/11/2008, EC decision date: 16/02/2009, Last updated: 13/03/2009 -
List item
Referral: Diovan Comp
valsartan and hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 26/05/2009, Last updated: 11/06/2009 -
List item
Referral: Durogesic and associated names
fentanyl, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 19/10/2016